A detailed history of Rhenman & Partners Asset Management Ab transactions in Novo Nordisk A S stock. As of the latest transaction made, Rhenman & Partners Asset Management Ab holds 100,000 shares of NVO stock, worth $10.5 Million. This represents 0.99% of its overall portfolio holdings.

Number of Shares
100,000
Holding current value
$10.5 Million
% of portfolio
0.99%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$119.07 - $145.42 $11.9 Million - $14.5 Million
100,000 New
100,000 $11.9 Million
Q4 2017

Jan 19, 2018

SELL
$47.53 - $53.73 $3.8 Million - $4.3 Million
-80,000 Closed
0 $0
Q3 2017

Oct 13, 2017

BUY
$41.15 - $49.22 $3.29 Million - $3.94 Million
80,000
80,000 $3.85 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $237B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Rhenman & Partners Asset Management Ab Portfolio

Follow Rhenman & Partners Asset Management Ab and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhenman & Partners Asset Management Ab, based on Form 13F filings with the SEC.

News

Stay updated on Rhenman & Partners Asset Management Ab with notifications on news.